Archives
-
Nitrocefin: Interpreting β-Lactamase Evidence
2026-10-08
Nitrocefin is a chromogenic cephalosporin substrate that makes β-lactamase activity visible, but its signal requires careful biological interpretation. This evidence-focused guide uses the GOB-38 study in Elizabethkingia anophelis to distinguish enzyme detection from broader claims about antibiotic resistance and inhibitor performance.
-
Exosomal IGFALS in Hepatocellular Carcinoma
2026-10-08
A 2026 study integrates public transcriptomic datasets, tissue immunohistochemistry, survival modeling, immune-infiltration analysis, and in vitro functional evidence to evaluate IGFALS in hepatocellular carcinoma. The findings position reduced IGFALS expression as a candidate prognostic signal, while the study’s retrospective and largely associative evidence means prospective validation is still required.
-
CCK-8 Plus for Interpreting PANoptosis Research
2026-10-07
Cell Counting Kit-8 Plus provides a sensitive tetrazolium salt assay for studying viability in inflammatory cell-death models. This article explains how WST-8 readouts can complement, but not replace, mechanistic evidence in lung ischemia–reperfusion research.
-
MTT as a Metabolic Lens in Mitochondrial Injury
2026-10-07
MTT is more than a routine colorimetric cell viability assay: it is a context-sensitive readout of cellular reducing capacity. This article connects MTT interpretation with mitochondrial ischemia-reperfusion research and explains how to distinguish metabolic recovery from true changes in cell survival.
-
TMB in P. vivax Serology: Evidence and Limits
2026-10-06
TMB is a chromogenic peroxidase substrate that can provide a measurable color signal in antibody-based assays. This overview examines its conceptual role in Plasmodium vivax epitope serology, the findings of a 2026 multi-region study, and the evidence limitations that separate promising biomarkers from validated surveillance tools.
-
BCA Protein Assay Kit: Evidence and Limits
2026-10-06
The BCA Protein Assay Kit is a colorimetric protein quantification assay based on alkaline copper reduction and bicinchoninic acid complex formation. Its reported sensitivity and linear range support protein concentration measurement, but matrix effects and the distinction between total protein and biological mechanism limit interpretation.
-
Reactive Oxygen Species Assay Kit: Evidence and Limits
2026-10-05
This overview places the APExBIO Reactive Oxygen Species Assay Kit and its DCFH-DA fluorescent probe in the context of cellular redox research. It examines what the assay can and cannot show, relates those boundaries to a 2026 study of tetrandrine in black sea bream myogenic cells, and distinguishes vendor information from peer-reviewed evidence.
-
Moxidectin: Anthelmintic Biology and Antifungal Evidence
2026-10-05
Moxidectin is a macrocyclic lactone anthelmintic with established antiparasitic activity and an emerging preclinical role in antifungal-synergy research. A 2024 study linked moxidectin–polyene synergy against Candida albicans to increased ergosterol biosynthesis, but the finding remains laboratory and mouse-model evidence rather than a clinical indication.
-
ARL4C, FLSs, and Macrophage Dynamics in RA
2026-10-04
A 2024 study integrates single-cell and bulk transcriptomic evidence with cellular and animal models to position ARL4C as a regulator of rheumatoid arthritis fibroblast-like synoviocyte behavior and macrophage polarization. Its findings support ARL4C as a mechanistically relevant candidate, while also highlighting the need for human validation and orthogonal measurements of proliferation and inflammatory function.
-
Morning Training Improves Endurance Adaptation in Mice
2026-10-03
Hesketh et al. found that endurance training during the early active phase produced a larger improvement in mouse running capacity than training during the late active phase, despite lower absolute training volumes. The study strengthens the case for exercise timing as a determinant of adaptation efficiency while showing that the observed performance difference was not explained by endpoint liver or muscle glycogen content alone.
-
WST-8 Assays for Smart Diabetic-Wound Hydrogels
2026-10-02
WST-8 provides a practical way to quantify cellular metabolic activity during evaluation of multifunctional diabetic-wound hydrogels. This guide explains how to interpret the assay when MnO2 nanozymes, dynamic micelles, and hydrogel matrices may create optical or chemical interference.
-
Ferroptosis Signatures and Atorvastatin in HCC
2026-10-01
Wang et al. integrate TCGA transcriptomics, survival modeling, Connectivity Map screening, and experimental validation to develop a four-gene ferroptosis-related prognostic signature for hepatocellular carcinoma. Their results identify Atorvastatin as a candidate compound that suppresses HCC growth and migration while promoting ferroptosis, although prospective validation and mechanistic clarification remain necessary.
-
Bradford Protein Assay Kit K4103: Practical Guide
2026-10-01
The Bradford Protein Assay Kit K4103 provides rapid protein concentration measurement from small liquid samples using Coomassie Brilliant Blue G-250 and supplied BSA standards. It is intended for compatible soluble samples within the stated working range, while detergent-rich, strongly chaotropic, compositionally atypical, or otherwise interfering matrices require validation or an alternative method.
-
ELP-Delivered p21 Peptide in Glioblastoma
2026-09-30
The reference study evaluates an elastin-like polypeptide and cell-penetrating peptide platform for delivering a p21-derived cell-cycle inhibitor into glioblastoma cells. Across U87, GBM43, and GBM6 models, the construct suppressed proliferation mainly through cytostatic effects, while confocal imaging supported sustained intracellular uptake and localization near the nucleus.
-
β-PGG Targets PCID2 in Hepatocellular Carcinoma
2026-09-30
A 2025 Frontiers in Pharmacology study combined structure-based virtual screening with surface plasmon resonance to identify β-PGG as a natural compound that directly binds PCID2. In HCC cell models, β-PGG inhibited proliferation, migration, and invasion while promoting apoptosis and cell-cycle arrest, providing a useful framework for evaluating PCID2-targeting leads.